Cite
Knudsen LS, Hetland ML, Johansen JS, et al. Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy. Biomark Insights. 2009;4:91-5doi: 10.4137/bmi.s2300.
Knudsen, L. S., Hetland, M. L., Johansen, J. S., Skjødt, H., Peters, N. D., Colic, A., Grau, K., Nielsen, H. J., & Ostergaard, M. (2009). Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy. Biomarker insights, 491-5. https://doi.org/10.4137/bmi.s2300
Knudsen, Lene Surland, et al. "Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy." Biomarker insights vol. 4 (2009): 91-5. doi: https://doi.org/10.4137/bmi.s2300
Knudsen LS, Hetland ML, Johansen JS, Skjødt H, Peters ND, Colic A, Grau K, Nielsen HJ, Ostergaard M. Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy. Biomark Insights. 2009 Sep 23;4:91-5. doi: 10.4137/bmi.s2300. PMID: 20029652; PMCID: PMC2796864.
Copy
Download .nbib